We are live on ! Find out more
BHC icon

Bausch Health

235 hedge funds and large institutions have $2.27B invested in Bausch Health in 2023 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 53 increasing their positions, 87 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

26% more capital invested

Capital invested by funds: $1.81B → $2.27B (+$466M)

17% more funds holding in top 10

Funds holding in top 10: 67 (+1)

2.45% less ownership

Funds ownership: 79.41%76.96% (-2.4%)

10% less funds holding

Funds holding: 262235 (-27)

39% less repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 87

45% less first-time investments, than exits

New positions opened: 29 | Existing positions closed: 53

71% less call options, than puts

Call options by funds: $75.8M | Put options by funds: $266M

Holders
235
Holders Change
-27
Holders Change %
-10.31%
% of All Funds
3.75%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.11%
New
29
Increased
53
Reduced
87
Closed
53
Calls
$75.8M
Puts
$266M
Net Calls
-$190M
Net Calls Change
-$128M
Name Holding Trade Value Shares
Change
Change in
Stake
RIM
51
Redwood Investment Management
Arizona
$3.64M -$102K -12,703 -3%
Qube Research & Technologies (QRT)
52
Qube Research & Technologies (QRT)
United Kingdom
$3.37M +$3.34M +416,291 New
AIMCA
53
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$3.22M -$1.63M -202,922 -34%
BCC
54
Biglari Capital Corp
Texas
$3.2M
Geode Capital Management
55
Geode Capital Management
Massachusetts
$2.98M -$762K -94,934 -23%
EH
56
EMG Holdings
Connecticut
$2.94M
BlackRock
57
BlackRock
New York
$2.89M -$216K -26,906 -7%
VanEck Associates
58
VanEck Associates
New York
$2.89M -$2.42M -301,015 -46%
AM
59
Ares Management
California
$2.64M -$837K -104,286 -24%
Barclays
60
Barclays
United Kingdom
$2.59M +$7.42K +924 +0.3%
T
61
TOBAM
France
$2.49M +$2.48M +308,486 New
Legal & General Group
62
Legal & General Group
United Kingdom
$2.33M +$90.3K +11,245 +4%
FA
63
Fountainhead AM
New Jersey
$2.25M
CIBC Asset Management
64
CIBC Asset Management
Ontario, Canada
$2.16M +$21.8K +2,709 +1%
WA
65
Whitebox Advisors
Minnesota
$2.07M -$2.57M -319,500 -56%
BFM
66
Boothbay Fund Management
New York
$2.01M -$333K -41,420 -14%
TIM
67
Thompson Investment Management
Wisconsin
$1.81M -$148K -18,480 -8%
Manulife (Manufacturers Life Insurance)
68
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.7M -$527K -65,584 -24%
LP
69
LMR Partners
United Kingdom
$1.64M +$1.26M +157,414 +350%
Thrivent Financial for Lutherans
70
Thrivent Financial for Lutherans
Minnesota
$1.49M +$1.48M +183,903 New
Northern Trust
71
Northern Trust
Illinois
$1.45M -$39.5K -4,918 -3%
Axa
72
Axa
France
$1.43M +$1M +125,008 +243%
PP
73
PDT Partners
New York
$1.41M +$677K +84,348 +95%
Acadian Asset Management
74
Acadian Asset Management
Massachusetts
$1.39M +$712K +88,700 +106%
SNT
75
SIG North Trading
Pennsylvania
$1.37M +$1.12M +139,932 +486%

BHC Hedge Fund Activity: Q1 2023 in Review

235 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q1 2023, worth a combined $2.27B — up 26% from $1.81B a quarter earlier.

Sellers outnumbered buyers: 53 funds closed out of BHC and 29 opened new positions — a net loss of 24 holders — while 87 trimmed existing stakes and 53 added.

The largest buyer was Bank of Montreal, adding an estimated $82M. The largest seller was Goldman Sachs, cutting an estimated $68.6M.

  • 235 institutional investors held Bausch Health (BHC) as of Q1 2023, down from 262 in Q4 2022.
  • Funds reported $2.27B of Bausch Health stock for Q1 2023, up 26% quarter-over-quarter.
  • 29 funds opened new Bausch Health positions in Q1 2023 and 53 closed out, a net change of -24 holders.
  • The largest Bausch Health buyer in Q1 2023 was Bank of Montreal, an estimated $82M added.
  • The largest Bausch Health seller in Q1 2023 was Goldman Sachs, an estimated $68.6M sold.

Based on aggregated 13F filings for Q1 2023.